FC
LLY icon

Fusion Capital’s Eli Lilly LLY Stock Holding History

Fusion Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.38M Sell
1,153
-43
-4% -$43.9K 0.32% 35
2026
Q1 		$1.1M Buy
1,196
+5
+0.4% +$5.07K 0.3% 39
2025
Q4 		$1.28M Buy
1,191
+1
+0.1% +$956 0.36% 37
2025
Q3 		$1.03M Sell
1,190
-228
-16% -$170K 0.3% 39
2025
Q2 		$1.11M Buy
1,418
+15
+1% +$11.7K 0.38% 38
2025
Q1 		$1.16M Buy
1,403
+1
+0.1% +$832 0.44% 34
2024
Q4 		$1.08M Sell
1,402
-3
-0.2% -$2.48K 0.44% 35
2024
Q3 		$1.24M Buy
1,405
+1
+0.1% +$899 0.53% 32
2024
Q2 		$1.27M Sell
1,404
-149
-10% -$119K 0.58% 31
2024
Q1 		$1.21M Buy
1,553
+2
+0.1% +$1.42K 0.55% 31
2023
Q4 		$904K Sell
1,551
-248
-14% -$145K 0.46% 32
2023
Q3 		$966K Hold
1,799
– – 0.54% 31
2023
Q2 		$844K Sell
1,799
-21,764
-92% -$9.13M 0.47% 31
2023
Q1 		$8.09M Sell
23,563
-1,263
-5% -$426K 4.63% 4
2022
Q4 		$9.08M Sell
24,826
-373
-1% -$132K 5.35% 4
2022
Q3 		$8.15M Sell
25,199
-839
-3% -$266K 5.31% 4
2022
Q2 		$8.44M Buy
26,038
+141
+0.5% +$42.3K 5.21% 4
2022
Q1 		$7.42M Buy
25,897
+833
+3% +$214K 3.89% 5
2021
Q4 		$6.92M Buy
25,064
+908
+4% +$230K 3.52% 6
2021
Q3 		$5.58M Buy
24,156
+520
+2% +$128K 3.31% 7
2021
Q2 		$5.42M Buy
23,636
+775
+3% +$156K 3.26% 7
2021
Q1 		$4.27M Sell
22,861
-273
-1% -$53.4K 2.78% 13
2020
Q4 		$3.91M Buy
23,134
+1,228
+6% +$183K 2.81% 10
2020
Q3 		$3.24M Sell
21,906
-849
-4% -$131K 2.82% 10
2020
Q2 		$3.74M Buy
22,755
+36
+0.2% +$5.53K 3.59% 6
2020
Q1 		$3.15M Sell
22,719
-1,584
-7% -$218K 3.77% 6
2019
Q4 		$3.19M Buy
+24,303
New +$2.82M 2.88% 9

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fusion Capital's LLY Position: Q2 2026 in Review

Fusion Capital reduced its Eli Lilly (LLY) stake by 3.6% in Q2 2026, selling an estimated $43.9K and leaving 1,153 shares worth $1.38M. The position accounts for 0.32% of the portfolio, ranked #35.

Fusion Capital first reported a position in LLY in Q4 2019 and has held it in 27 quarters since. The position peaked at $9.08M in Q4 2022. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Fusion Capital held 1,153 shares of Eli Lilly worth $1.38M as of Q2 2026.
  • Fusion Capital sold 43 Eli Lilly shares in Q2 2026, an estimated $43.9K.
  • Eli Lilly made up 0.32% of Fusion Capital's portfolio in Q2 2026, its #35 holding.
  • Fusion Capital first reported a position in Eli Lilly in Q4 2019 and has held it in 27 quarters since.
  • Fusion Capital's Eli Lilly position peaked at $9.08M in Q4 2022.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Fusion Capital's 13F filing for Q2 2026, filed 5 Aug 2026.